CLINICAL_TRIALS
trial_result
· 2018-05-17
Clinical Trial Update: Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery [Phase 4]
Summary
Phase 4 trial evaluating sitagliptin for stress hyperglycemia or mild diabetes after cardiac surgery was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kathleen Dungan | Conditions: Diabetes Mellitus, Type 2, Hyperglycemia | Phase 4 | Status: TERMINATED | Results posted: 2018-05-17